Letter: impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease
Aliment Pharmacol Ther
.
2019 Feb;49(4):476-477.
doi: 10.1111/apt.15104.
Authors
Tehmina Ahmed
1
,
Francesca Brown
1
,
Ruhina Ahmed
1
,
Ash Shah
1
,
Simon Whitehead
1
,
Helen Steed
1
,
Matthew J Brookes
1
Affiliation
1
Royal Wolverhampton NHS Trust, Wolverhampton, UK.
PMID:
30689253
DOI:
10.1111/apt.15104
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Adult
Epstein-Barr Virus Infections*
Herpesvirus 4, Human
Humans
Inflammatory Bowel Diseases*
Grants and funding
Tillotts Pharma/International
Vifor Pharma/International